Two recent studies reveal that a novel profibrotic macrophage subset differentiated from circulating monocytes, CD9+TREM2+ macrophage, is significantly increased in patients with liver cirrhosis and plays a key role in activating HSCs at least via releasing TGF-β [61, 62]. This evidence concerns the gene CD9 and cirrhosis of liver.